SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-19-005753
Filing Date
2019-04-04
Accepted
2019-04-04 09:17:02
Documents
5
Period of Report
2019-04-04

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER f6k040419_canfitebio.htm 6-K 33850
2 OPINION OF DORON TIKOTZKY KANTOR GUTMAN & AMIT GROSS f6k040419ex5-1_canfite.htm EX-5.1 25115
3 FORM OF SECURITIES PURCHASE AGREEMENT DATED AS OF APRIL 2, 2019 BETWEEN CAN-FITE f6k040419ex10-1_canfite.htm EX-10.1 243815
4 FORM OF WARRANT TO BE ISSUED BY CAN-FITE BIOPHARMA LTD. ON APRIL 4, 2019 f6k040419ex10-2_canfite.htm EX-10.2 100796
5 GRAPHIC ex5-1_001.jpg GRAPHIC 16426
  Complete submission text file 0001213900-19-005753.txt   427400
Mailing Address 10 BAREKET STREET, KIRYAT MATALON P.O. BOX 7537 PETACH TIKVA L3 4951778
Business Address 10 BAREKET STREET, KIRYAT MATALON P.O. BOX 7537 PETACH TIKVA L3 4951778 972 39241114
Can-Fite BioPharma Ltd. (Filer) CIK: 0001536196 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36203 | Film No.: 19731287
SIC: 2834 Pharmaceutical Preparations